1. "Biomed Central Ltd"
  2. "Center for Hematologic Malignancies"
Formats
  1. Journal Article (54)
  2. Meeting Abstract (17)
  3. Review (4)
  4. Guidelines (3)
  5. Research Letter (1)
Groups
  1. Center for Hematologic Malignancies (79)
  2. Department of Medicine (61)
  3. Hematologic Malignancies, Division of (61)
  4. GSK Faculty (41)
  5. Adult Leukemia (30)
  6. Hematologic Malignancies Research (26)

More Groups

People
  1. Jae Park (5)
  2. Michel Sadelain (5)
  3. Ross Levine (5)
  4. Alex Kentsis (4)
  5. Eytan Stein (4)
  6. Jedd Wolchok (4)

More People

Years
  1. 2023 (2)
  2. 2022 (7)
  3. 2021 (9)
  4. 2020 (7)
  5. 2019 (6)
  6. 2018 (7)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (26)
  2. Journal of Hematology & Oncology (18)
  3. BMC Bioinformatics (3)
  4. BMC Cancer (3)
  5. Genome Biology (3)
  6. Genome Medicine (3)

More Publications

Publishers
  1. Biomed Central Ltd (79)

Results (79)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The landscape of MHC-presented phosphopeptides yields actionable shared tumor antigens for cancer immunotherapy across multiple HLA alleles
    Journal Article

    Molvi, Z.; Klatt, M. G.; Dao, T.; Urraca, J.; Scheinberg, D. A.; O'Reilly, R. J.
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3
    Journal Article

    Shah, B. D.; Cassaday, R. D.; Park, J. H.; Houot, R.; Oluwole, O. O.; Logan, A. C.; Boissel, N.; Leguay, T.; Bishop, M. R.; Topp, M. S.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study
    Journal Article

    Shah, B. D.; Ghobadi, A.; Oluwole, O. O.; Logan, A. C.; Boissel, N.; Cassaday, R. D.; Leguay, T.; Bishop, M. R.; Topp, M. S.; Tzachanis, D.; more...
    Journal of Hematology & Oncology (2022)

    Fulltext@MSK | Save
  • Phase 1 study of intraventricular (131)I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies
    Journal Article

    Kramer, K.; Pandit-Taskar, N.; Kushner, B. H.; Zanzonico, P.; Humm, J. L.; Tomlinson, U.; Donzelli, M.; Wolden, S. L.; Haque, S.; Dunkel, I.; more...
    Journal of Hematology & Oncology (2022)

    Fulltext@MSK | Save
  • Modelling multiple time-scales with flexible parametric survival models
    Journal Article

    Batyrbekova, N.; Bower, H.; Dickman, P. W.; Ravn Landtblom, A.; Hultcrantz, M.; Szulkin, R.; Lambert, P. C.; Andersson, T. M. L.
    BMC Medical Research Methodology (2022)

    Fulltext@MSK | Save
  • A clinician perspective on the treatment of chronic myeloid leukemia in the chronic phase
    Review

    García-Gutiérrez, V.; Breccia, M.; Jabbour, E.; Mauro, M.; Cortes, J. E.
    Journal of Hematology & Oncology (2022)

    Fulltext@MSK | Save
  • Navigating a newly diagnosed cancer through clinician-facilitated discussions of health-related patient values: A qualitative analysis
    Journal Article

    Lynch, K. A.; Bernal, C.; Romano, D. R.; Shin, P.; Nelson, J. E.; Okpako, M.; Anderson, K.; Cruz, E.; Desai, A. V.; Klimek, V. M.; more...
    BMC Palliative Care (2022)

    Fulltext@MSK | Save
  • CD19-directed chimeric antigen receptor T cell therapy in Waldenström macroglobulinemia: A preclinical model and initial clinical experience
    Journal Article

    Palomba, M. L.; Qualls, D.; Monette, S.; Sethi, S.; Dogan, A.; Roshal, M.; Senechal, B.; Wang, X.; Rivière, I.; Sadelain, M.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Retrospective analysis of arterial occlusive events in the PACE trial by an independent adjudication committee
    Journal Article

    Januzzi, J. L.; Garasic, J. M.; Kasner, S. E.; McDonald, V.; Petrie, M. C.; Seltzer, J.; Mauro, M.; Croce, K.; Berman, E.; Deininger, M.; more...
    Journal of Hematology & Oncology (2022)

    Fulltext@MSK | Save
  • High quality neoantigens are immunoedited in long-term pancreatic cancer survivors
    Meeting Abstract

    Sethna, Z.; Luksza, M.; Rojas, L.; Soares, K.; Leung, J.; Lihm, J.; Hoyos, D.; Dobrin, A.; Kappagantula, R.; Makohon-Moore, A.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save